期刊文献+

中西药相互作用的药代动力学机制研究进展 被引量:23

Advancement in pharmacokinetic mechanisms of herb-drug interaction
下载PDF
导出
摘要 近年来,中西药联合应用日益增多,引起诸多药物相互作用和不良反应。药物代谢酶和转运体在药物的体内代谢和处置过程中发挥重要的作用,中西药联用不仅会改变药物的理化性质和人体的生理特性,而且可以调节药物代谢酶和转运体的表达和功能,进而产生药动学相互作用,引起药物疗效的改变。本文对中西药相互作用的药动学基础及其评价方法进行总结,旨在为中西药的联合应用和研究提供参考。 Recently, there is a dramatic increase in the combination use of traditional Chinese medicine and western drug, causing various drug interactions and adverse effects. This combination can not only change physiochemical properties of the related drugs and physiological nature of human body, but regulate expression and function of drug metabolizing enzymes and transporters, which play key role in drug metabolism and disposition in vivo. Pharmacokinetic interaction then takes place frequently, together with alteration in clinical outcome. The paper summarizes the pharmacokinetics and assessment approaches of herb-drug interaction, acting as a reference for practical use and research.
出处 《中国临床药理学与治疗学》 CAS CSCD 2014年第4期470-476,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 江苏省创新平台提升项目(BM2012012) 江苏省自然科学基金(BK20131308)
关键词 中药 药物相互作用 药代动力学 药物 代谢酶 转运体 traditional Chinese medicine drug interaction pharmacokinetics drug-me-tabolizing enzymes transporter
  • 相关文献

参考文献38

  • 1Voruganti S, Yamsani SK, Yamsani MR. Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits [J]. Eur J Drug Metab Pharmacokinet, 2013.
  • 2Schwarz UI, Hanso H, Oertel R, et al. Induction of intestinal P-glycoprotein by St John's wort re- duces the oral bioavailability of talinolol[J]. Clin Pharmacol Ther, 2007, 81(5) :669-678.
  • 3Hou YC, Lin SP, Chao PD. Liquorice reduced cy closporine bioavailability by activating P-glycopro tein and CYP 3A[J]. Food Chem, 2012,135 (4) :2307-2312.
  • 4Mandery K, Bujok K, Schmidt I, et al. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting poly peptides 1A2 and 2B1[J].Biochem Pharmacol, 2010,80(11) :1746-1753.
  • 5Zhou F, Zhang J, Li P, et al. Toward a new age of cellular pharmacokinetics in drug discovery [ J]. Drug Metab Rev, 2011,43(3) :335-345.
  • 6Zheng Y, Zhou F, Wu X, et al. 23-Hydroxybetu- linic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo [J]. J Ethnopharmacol, 2010,128 (3) :615-622.
  • 7Zhang J, Zhou F, Wu X, et al. Cellular pharmaco kinetic mechanisms of adriamycin resistance and its modulation by 20 (S)-ginsenoside Rh2 in MCF 7/ Adrcells[J]. Br J Pharmacol, 2012,165(1):120- 134.
  • 8Zhang DM, He ZW, Liu XD, et al. Ircvivo and in- vitro studies on the effect of Huang-Lian-Jie-Du- Tang on nimodipine transport across rat blood-brain barrier[J].J Pharm Pharmacol, 2007, 59 (12) : 1733-1738.
  • 9Taki Y, Yokotani K, Yamada S, et al. Ginkgo bi loba extract attenuates warfarin-mediated anticoagu- lation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice[J]. Phytomedicine, 2012,19(2):177-182.
  • 10Malati CY, Robertson SM, Hunt JD, et al. Influ- ence of Panax ginseng on cytochrome P450 (CYP) 3A and P glycoprotein (P-gp) activity in healthy participants[J]. J Clin Pharmacol, 2012, 52 (6): 932 -939.

二级参考文献59

  • 1Markov GV,Laudet V. Origin and evolution of theligand-binding ability of nuclear receptors [J], MolCell Endocrinol, 2011,334(1/2) :21 -30.
  • 2Merk D, Schubert-Zsilavecz M. Nuclear receptorsas pharmaceutical targets:rise of FXR and rebirth ofPPAR[J]. Future Med Chem,2012, 4 (5) : 587 -588.
  • 3Swanson H, Wada T,Xie W. et al. Role of Nucle-ar Receptors in Lipid Dysfunction and Obesity-relat-ed Diseases[J]. Drug Metab Dispos, 2013 ,41(1) : 1-11.
  • 4Li L, Stanton JD, Tolson AH, et al. Bioactive ter-penoids and flavonoids from Ginkgo biloba extractinduce the expression of hepatic drug-metabolizingenzymes through pregnane X receptor, constitutiveandrostane receptor, and aryl hydrocarbon receptor-mediated pathways[J], Pharm Res,2009,26 (4):872-882.
  • 5Tirona RG. Molecular mechanisms of drug trans-porter regulation[J]. Handb Exp Pharmacol, 2011,(201) :373-402.
  • 6Kobayashi K,Saito K,Takagi S, et al. Ligand-De-pendent Assembly of Pregnane X Receptor, Consti-tutive Androstane Receptor and Liver X Receptor isApplicable to Identify Ligands [J]. Drug MetabLett,2010,4(2) :88 - 94.
  • 7Kliewer SA,Moore JT, Wade L, et al. An orphannuclear receptor activated by pregnanes defines anovel steroid signaling pathway[J]. Cell, 1998. 92(1):73-82.
  • 8Koyano S,Kurose K, Saito Y, et al. Functionalcharacterization of four naturally occurring variantsof human pregnane X receptor (PXR) : one variantcauses dramatic loss of both DNA binding activityand the transactivation of the CYP3A4 promoter/enhancer region [J]. Drug Metab Dispos, 2004, 32(1),149-154.
  • 9Squires EJ, Sueyoshi T,Negishi M. Cytoplasmiclocalization of pregnane X receptor and ligand-de-pendent nuclear translocation in mouse liver [J]. JBiol Chem, 2004,279(47): 49307-49314.
  • 10Kawana K,Ikuta T,Kobayashi Y,et al. Molecularmechanism of nuclear translocation of an orphan nu-clear receptor, SXR[J]. Mol Pharmacol, 2003, 63(3):524-531.

共引文献3

同被引文献354

引证文献23

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部